Safety and Efficacy Phase 2 Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient Children

NCT01592500 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

56

Enrollment

INDUSTRY

Sponsor class

Conditions

Pediatric Growth Hormone Deficiency

Interventions

DRUG: MOD-4023
DRUG: Somatropin

Sponsor

OPKO Health, Inc.